Table of Contents

August 15, 2026; Volume 23,Issue 8

  1. Agrawal, Kajal

    1. Open Access
      Dietary restriction during active cancer therapy is associated with improved treatment response: a systematic review and meta-analysis
      Kajal Agrawal, Dominic Shao Yong Goh, Ee Chern Ng, Shyn Yi Tan, Carlos Cifuentes-González, Jason Xing Kang, William K. K. Wu, Rashid N. S. Lui, Rupesh Agrawal, Yusuf Ali and Sunny H. Wong
      Cancer Biology & Medicine August 2026, 23 (8) 1193-1197; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0841

  2. Agrawal, Rupesh

    1. Open Access
      Dietary restriction during active cancer therapy is associated with improved treatment response: a systematic review and meta-analysis
      Kajal Agrawal, Dominic Shao Yong Goh, Ee Chern Ng, Shyn Yi Tan, Carlos Cifuentes-González, Jason Xing Kang, William K. K. Wu, Rashid N. S. Lui, Rupesh Agrawal, Yusuf Ali and Sunny H. Wong
      Cancer Biology & Medicine August 2026, 23 (8) 1193-1197; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0841

  3. Ali, Yusuf

    1. Open Access
      Dietary restriction during active cancer therapy is associated with improved treatment response: a systematic review and meta-analysis
      Kajal Agrawal, Dominic Shao Yong Goh, Ee Chern Ng, Shyn Yi Tan, Carlos Cifuentes-González, Jason Xing Kang, William K. K. Wu, Rashid N. S. Lui, Rupesh Agrawal, Yusuf Ali and Sunny H. Wong
      Cancer Biology & Medicine August 2026, 23 (8) 1193-1197; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0841

  4. Cai, Yiran

    1. Open Access
      Myeloid cell reprogramming combined with zoledronic acid effectively suppresses bone metastasis
      Yuting Luo, Yiran Cai, Zizheng Jiang, Ke Zheng, Shiji Ren, Lixia Yu, Baorui Liu, Tao Shi and Jia Wei
      Cancer Biology & Medicine August 2026, 23 (8) 1167-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0168

  5. Cai, Zhigang

    1. Open Access
      Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH)
      Lisha Shen, Dongqing Lv, Ke-Jing Tang, Jun Zhao, Dan Zhu, Yanqiu Zhao, Ke Wang, Yan Wang, Zhigang Cai, Ligang Xing, Ke Xie, Jiuwei Cui, Lin Mu, Chao Cao, Liren Ding, Peifeng Chen, Jun Liang, Yongmin Ding, Liqin Lu, Jiliang Zhang, Xinmin Yu, Li Chen, Jing Zheng, Jianya Zhou and Jianying Zhou
      Cancer Biology & Medicine August 2026, 23 (8) 1156-1166; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0566

  6. Cao, Chao

    1. Open Access
      Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH)
      Lisha Shen, Dongqing Lv, Ke-Jing Tang, Jun Zhao, Dan Zhu, Yanqiu Zhao, Ke Wang, Yan Wang, Zhigang Cai, Ligang Xing, Ke Xie, Jiuwei Cui, Lin Mu, Chao Cao, Liren Ding, Peifeng Chen, Jun Liang, Yongmin Ding, Liqin Lu, Jiliang Zhang, Xinmin Yu, Li Chen, Jing Zheng, Jianya Zhou and Jianying Zhou
      Cancer Biology & Medicine August 2026, 23 (8) 1156-1166; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0566

  7. Cao, Tianyu

    1. Open Access
      Tumor microenvironment-driven natural killer cell diversity: mechanisms and therapeutic opportunities
      Yue Duan, Mingzhen Zhou, Xingxian Guo, Tianyu Cao, Yuanyuan Lu and Xiaodi Zhao
      Cancer Biology & Medicine August 2026, 23 (8) 1087-1107; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0829

  8. Chen, Kezhong

    1. Open Access
      Harnessing the microbiome: a new frontier in lung cancer immunotherapy
      Kexin Feng, Jun Wang, Shuai Wang, Zewen Sun, Mantang Qiu, Zuli Zhou, Yun Li and Kezhong Chen
      Cancer Biology & Medicine August 2026, 23 (8) 1057-1086; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0177

  9. Chen, Li

    1. Open Access
      Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH)
      Lisha Shen, Dongqing Lv, Ke-Jing Tang, Jun Zhao, Dan Zhu, Yanqiu Zhao, Ke Wang, Yan Wang, Zhigang Cai, Ligang Xing, Ke Xie, Jiuwei Cui, Lin Mu, Chao Cao, Liren Ding, Peifeng Chen, Jun Liang, Yongmin Ding, Liqin Lu, Jiliang Zhang, Xinmin Yu, Li Chen, Jing Zheng, Jianya Zhou and Jianying Zhou
      Cancer Biology & Medicine August 2026, 23 (8) 1156-1166; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0566

  10. Chen, Peifeng

    1. Open Access
      Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH)
      Lisha Shen, Dongqing Lv, Ke-Jing Tang, Jun Zhao, Dan Zhu, Yanqiu Zhao, Ke Wang, Yan Wang, Zhigang Cai, Ligang Xing, Ke Xie, Jiuwei Cui, Lin Mu, Chao Cao, Liren Ding, Peifeng Chen, Jun Liang, Yongmin Ding, Liqin Lu, Jiliang Zhang, Xinmin Yu, Li Chen, Jing Zheng, Jianya Zhou and Jianying Zhou
      Cancer Biology & Medicine August 2026, 23 (8) 1156-1166; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0566
« Previous (Pages : 1 2 3 4 5 6 ... 10) Next »
Back to top

In this issue

Cancer Biology & Medicine: 23 (8)
Cancer Biology & Medicine
Vol. 23, Issue 8
15 Aug 2026

Submit

Sign up for alerts